|
|
||||||||
Original Research Communication |
1 From the Endocrine Unit (APG, MAG, and SRB), the Department of Dietetics (AEB and GF), and the Robert Steiner MRI Unit (ELT and JDB), MRC Clinical Sciences Centre, Imperial College School of Medicine, Hammersmith Hospital, London, and the Department of Psychiatry, University of Cambridge, Cambridge, United Kingdom (AH).
Background: Obesity in Prader-Willi syndrome (PWS) may be related to abnormalities in the adipocyte-leptin-hypothalamic pathway and may be exacerbated by reductions in the resting metabolic rate (RMR).
Objective: We compared body composition, body-composition adjusted RMR, and adiposity-adjusted plasma leptin between women with PWS and control women. We also examined leptin receptor expression in the PWS group.
Design: We studied body composition using whole-body magnetic resonance imaging and measured plasma leptin by radioimmunoassay in 45 control women aged 1856 y and in 13 women with PWS aged 2038 y. RMR was measured by indirect calorimetry in 41 control women and in 8 women with PWS. Age, body composition, and regional adipose tissue (AT) depots were corrected for by multiple regression analysis. Messenger RNA expression of the leptin receptor was examined by reverse transcriptasepolymerase chain reaction in lymphocytes.
Results: In the PWS group, fat mass was greater after correction for fat-free mass, and RMR was normal after correction for both fat-free mass and fat mass. Leptin was influenced primarily by subcutaneous AT volume in both subject groups. Leptin concentrations were not significantly different between the 2 groups after adjustment for age and AT content or distribution. Full-length leptin receptor messenger RNA was expressed in the lymphocytes of the PWS group.
Conclusions: Differences in RMR in women with PWS are explained by abnormal body composition, suggesting that energy expenditure is normal at the tissue level in PWS. There is no evidence that defective leptin production causes obesity in PWS, and leptin receptor deficiency is not a primary consequence of the gene defects leading to leptin resistance.
Key Words: Magnetic resonance imaging MRI obesity body fat Prader-Willi syndrome fat distribution resting metabolic rate growth hormone deficiency hypogonadism women
This article has been cited by other articles:
![]() |
J. M. Bischof, C. L. Stewart, and R. Wevrick Inactivation of the mouse Magel2 gene results in growth abnormalities similar to Prader-Willi syndrome Hum. Mol. Genet., November 15, 2007; 16(22): 2713 - 2719. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L Miller, G A. James, A. P Goldstone, J. A Couch, G. He, D. J Driscoll, and Y. Liu Enhanced activation of reward mediating prefrontal regions in response to food stimuli in Prader-Willi syndrome J. Neurol. Neurosurg. Psychiatry, June 1, 2007; 78(6): 615 - 619. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rodriguez-Jato, R. D. Nicholls, D. J. Driscoll, and T. P. Yang Characterization of cis- and trans-acting elements in the imprinted human SNURF-SNRPN locus Nucleic Acids Res., August 22, 2005; 33(15): 4740 - 4753. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Goldstone, E. L. Thomas, A. E. Brynes, G. Castroman, R. Edwards, M. A. Ghatei, G. Frost, A. J. Holland, A. B. Grossman, M. Korbonits, et al. Elevated Fasting Plasma Ghrelin in Prader-Willi Syndrome Adults Is Not Solely Explained by Their Reduced Visceral Adiposity and Insulin Resistance J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1718 - 1726. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |